BioCentury
ARTICLE | Emerging Company Profile

RedCell: Permanent bonds

July 14, 1997 7:00 AM UTC

Emerging Company Profile

Many drugs fail in development because they are rapidly metabolized or cleared from the body too rapidly to have a therapeutic effect. Others must be given at such high doses that they cause toxicities and side effects...